SCHEMBL3753380

SCHEMBL3753380

O=C1CCc2ccccc2C1Cc1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.54
HPGD P15428 2/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
GAA P10253 2/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP2D6 P10635 2/20 0.44
RET P07949 1/20 0.42
HTR2A P28223 1/20 0.42
CES2 O00748 1/20 0.41
ACP3 P15309 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6823296 0.75 HTR2A (0.50) RETHTR2A
SCHEMBL3753138 0.74 RET (0.42) RETHTR2ACYP1A2
SCHEMBL1870242 0.72 HTR2A (0.53) RETHTR2AACP3
SCHEMBL6185636 0.71 PRCP (0.60) ALDH1A1GAACYP2D6KDM4ESMN1; SMN2
SCHEMBL6823777 0.71 HTR2A (0.45) ALDH1A1MEN1KMT2AGAARET
SCHEMBL7926695 0.69 HTR2A (0.50) RETHTR2AACP3
SCHEMBL15670558 0.68 MAPT (0.62) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL7926747 0.68 HTR2A (0.49) ALDH1A1KMT2ARETHTR2AACP3
SCHEMBL13045133 0.68 ALDH1A1 (0.61) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2996388 0.68 MAPT (0.65) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838130-B2 Aminodibenzofluorene derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-23 US disclosed
US-20090267491-A1 AMINODIBENZOFLUORENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090267491-A1 AMINODIBENZOFLUORENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME L1CAM, DDC, LEF1 ALDH1A1 35/4885MAPT 2095/4885HPGD 3612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.